JUDITH A. SHIZURU, MD,PHD
Osteopathic Medicine at Pasteur Dr, Palo Alto, CA
License number
California G79769
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
300 Pasteur Dr, Palo Alto, CA 94305
Phone
(650) 497-8000
Organization information
See more information about JUDITH A. SHIZURU at bizstanding.comJudith Shizuru MD
300 Pasteur Dr #H0101, Stanford, CA 94305
Industry:
Internist
Doing business as:
Judith Shizuru MD,PHD
Phone:
(650) 723-0822 (Phone)
Description:
There are 10 doctors at this site. Surgery is not performed at this site.
Judith Anne Shizuru
Categories:
Physicians & Surgeons
Professional information
Judith Anne Shizuru, Stanford CA
Specialties:
Internal Medicine, Hematology & Oncology
Work:
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford, CA 94305
300 Pasteur Dr, Stanford, CA 94305
Education:
Stanford University (1992)
Dr. Judith A Shizuru, Stanford CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
Stanford Blood/Marrow Transplnt
300 Pasteur Dr STE H0101, Stanford 94305
(650) 723-0822 (Phone)
300 Pasteur Dr STE H0101, Stanford 94305
(650) 723-0822 (Phone)
Certifications:
Internal Medicine, 1997
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Stanford Blood/Marrow Transplnt
300 Pasteur Dr STE H0101, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
300 Pasteur Dr STE H0101, Stanford 94305
Stanford Hospital and Clinics
300 Pasteur Dr, Stanford 94305
Education:
Medical School
Stanford University
Graduated: 1992
University Ca Sf School Of Med
Stanford University
Graduated: 1992
University Ca Sf School Of Med
Lung Rpogenitor Cells, Assays, And Uses Thereof
US Patent:
2011006, Mar 10, 2011
Filed:
Jun 18, 2007
Appl. No.:
12/308351
Inventors:
Joseph H. Lin - Menlo Park CA, US
Judith A. Shizuru - Palo Alto CA, US
Judith A. Shizuru - Palo Alto CA, US
International Classification:
A01K 67/00, C12N 5/00, C12N 5/02, A61K 35/12, C12N 5/07
US Classification:
800 9, 435325, 435383, 424 937, 435354
Abstract:
Substantially enriched mammalian lung endothelial and epithelial progenitor cell populations are provided. Methods are provided for the isolation and in vivo differentiation of such lung progenitor cells. The progenitor cells are obtained from lung tissue, including fetal and adult tissues. The cells are useful in transplantation, for experimental evaluation, and as a source of lineage and cell specific products, including mRNA species useful in identifying genes specifically expressed in these cells, and as targets for the discovery of factors or molecules that can affect them.